Wednesday, 09 Oct 2024 (06:00 PM - 08:00 PM) Central Time (US & Canada)
2.0 RAC
The session will:
- Provide an understanding of the general principles of the EU AI Act and its regulatory and quality consequences, with a special focus on medical devices and health software. We will
- Explore the Act's risk classification system, ranging from minimal risk to high risk, and learn how different AI applications are regulated based on their potential impact.
Following the general presentations, there will be discussion on the potential challenges and opportunities the Act presents for innovation in the AI and medical device sectors.
Click here to register today!
------------------------------
Danielle Pennant
Chapter Events Specialist
------------------------------